French penalties could force clinical trials abroad
This article was originally published in Clinica
Executive Summary
The manner in which the French government is transposing the EU's clinical trials directive into its public health law could deter medical device companies from conducting their clinical trials in France, the French medical device industry association, SNITEM, is warning.